Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Manet

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Nucleic Acids Research|December 25, 1995
RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2L Waltzer, P Y Bourillot, A Sergeant, et al.
The EMBO Journal|March 1, 1987
Structure and sequence of the Drosophila zeste geneV Pirrotta, E Manet, E Hardon, et al.
Nucleic Acids Research|May 25, 1991
Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activationE Manet, A Rigolet, H Gruffat, et al.
Journal of Virology|February 1, 1989
The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein RA Chevallier-Greco, H Gruffat, E Manet, et al.
Gene Expression|January 1, 1993
The acidic activation domain of the Epstein-Barr virus transcription factor R interacts in vitro with both TBP and TFIIB and is cell-specifically potentiated by a proline-rich regionE Manet, C Allera, H Gruffat, et al.
The EMBO Journal|December 1, 1994
The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elementsL Waltzer, F Logeat, C Brou, et al.
The EMBO Journal|December 1, 1986
Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoterA Chevallier-Greco, E Manet, P Chavrier, et al.
Journal of Virology|May 1, 1985
Construction and use of cDNA clones for the mapping and identification of Epstein-Barr virus early P3HR-1 mRNAsE Manet, A Chevallier, C X Zhang, et al.
Journal of Clinical Microbiology|October 1, 1993
Use of monoclonal antibodies to distinguish pathogenic Naegleria fowleri (cysts, trophozoites, or flagellate forms) from other Naegleria speciesO Sparagano, E Drouet, R Brebant, et al.
Journal of Virology|December 1, 1989
The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and RM Buisson, E Manet, M C Trescol-Biemont, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Nucleic Acids Research|December 25, 1995
RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2L Waltzer, P Y Bourillot, A Sergeant, et al.
The EMBO Journal|March 1, 1987
Structure and sequence of the Drosophila zeste geneV Pirrotta, E Manet, E Hardon, et al.
Nucleic Acids Research|May 25, 1991
Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activationE Manet, A Rigolet, H Gruffat, et al.
Journal of Virology|February 1, 1989
The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein RA Chevallier-Greco, H Gruffat, E Manet, et al.
Gene Expression|January 1, 1993
The acidic activation domain of the Epstein-Barr virus transcription factor R interacts in vitro with both TBP and TFIIB and is cell-specifically potentiated by a proline-rich regionE Manet, C Allera, H Gruffat, et al.
The EMBO Journal|December 1, 1994
The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elementsL Waltzer, F Logeat, C Brou, et al.
The EMBO Journal|December 1, 1986
Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoterA Chevallier-Greco, E Manet, P Chavrier, et al.
Journal of Virology|May 1, 1985
Construction and use of cDNA clones for the mapping and identification of Epstein-Barr virus early P3HR-1 mRNAsE Manet, A Chevallier, C X Zhang, et al.
Journal of Clinical Microbiology|October 1, 1993
Use of monoclonal antibodies to distinguish pathogenic Naegleria fowleri (cysts, trophozoites, or flagellate forms) from other Naegleria speciesO Sparagano, E Drouet, R Brebant, et al.
Journal of Virology|December 1, 1989
The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and RM Buisson, E Manet, M C Trescol-Biemont, et al.
Pageof 3